A disorder in this tissue triggers reduced production of adipocytokines, such as adiponectin, and upregulation of the expression of leptin, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), promoting insulin resistance in association with increased visceral adiposity [14,39]. Here, ADIPOQ is linked to Insulin resistance.